Smart sensors could revolutionize rett syndrome monitoring

NCT ID NCT06338267

Recruiting now Knowledge-focused Sponsor: Rett Syndrome Research Trust Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests whether wearable biosensors can accurately track symptoms like heart rate, breathing, sleep, and movement in people with Rett syndrome. Up to 30 participants will use the devices at home for 9 weeks and also undergo one overnight sleep study in the clinic. The goal is to validate these tools for use in future clinical trials, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could make it easier to measure Rett symptoms accurately in future trials, helping test new treatments more effectively.
What could go wrong: This is a small, early-stage validation study (30 participants) focused on devices, not a treatment. The biosensors may not work reliably for all individuals with Rett syndrome.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETT SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Rett syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETT SYNDROME

Contacts and locations

Locations

Baylor College of Medicine
NOT_YET_RECRUITING

Houston, Texas, 77030, United States
Boston Children's Hospital
RECRUITING

Boston, Massachusetts, 02115, United States
Rush University Medical Center
RECRUITING

Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.